Abstract
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
L M Detora, D Krupa, J Bolognese, R S Sperling and E W Ehrich
The Journal of Rheumatology November 2001, 28 (11) 2494-2503;
L M Detora
D Krupa
J Bolognese
R S Sperling
In this issue
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
L M Detora, D Krupa, J Bolognese, R S Sperling, E W Ehrich
The Journal of Rheumatology Nov 2001, 28 (11) 2494-2503;